Nicolas Fouché

Nicolas Fouché has an extensive work experience in the healthcare industry. Nicolas is currently serving as the Senior Vice President International at Nestlé Health Science since December 2020. Prior to this, they held the position of General Manager and Vice-President, France and UK at Aimmune Therapeutics, where they successfully built teams and launched the first medication for Food Allergies in children. Aimmune Therapeutics was acquired by Nestlé in October 2020.

Before joining Aimmune Therapeutics, Nicolas worked at Gilead Sciences for a significant period of time. Their roles at Gilead Sciences included General Manager, Eastern Europe, Commercial Operations Director for EMEA, and Associate Director, International Commercial Strategy.

Before their tenure at Gilead Sciences, Nicolas worked as a Strategy Consultant (Healthcare) at a-connect. Nicolas also gained experience as a Trustee and Treasurer at Comme a la Maison (CALM).

Nicolas began their career at AstraZeneca, where they held various positions including Director, Sales Force Effectiveness (France), Director, Licensing, M&A and Planning (Japan), and Marketing and Sales positions (UK).

Prior to their industry experience, Nicolas worked as a Strategy Consultant at Boston Consulting Group (BCG), where they handled projects in healthcare, banking, retail, and services.

Overall, Nicolas Fouché has demonstrated a wealth of experience in leadership, strategy, and commercial roles within the healthcare industry.

Nicolas Fouché obtained an MBA in Management and Economics from ESSEC Business School, where they studied from 1996 to 1999. Nicolas further pursued their education at Harvard Law School and completed the Programme on Negotiation before the year 2018.